CCCC vs O · rev $35.6M vs P/E 50, rev $5.27B
C4 Therapeutics Inc (CCCC) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
CCCC currently screens at market cap $425.7M. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the CCCC and O stock pages for the full models.
Not investment advice.